Author
Listed:
- Dr. A. Geethalakshmi
(Professor & HOD, R R College of Pharmacy, Department of Pharmaceutics, Bangalore-68, Karnataka, India)
- Kunga Gyaltsen
(The Oxford R R College of Pharmacy, Department of Pharmaceutics, Bangalore-90, Karnataka, India)
Abstract
The present study is aimed at preparing a fast disintegrating oral film of Betaxolol Hydrochloride for the treatment of hypertension using solvent casting method. In the formulation of fast disintegrating mouth films, various trials have been carried out using two grades of HPMC (E15 and E50) as film forming polymer, PEG-4000 as plasticizer, citric acid as saliva stimulating agent, peppermint oil as flavoring agent and sucrose as sweetener. The prepared films were evaluated for film thickness, folding endurance, surface pH, morphological properties, %drug content, tensile strength, In vitro disintegration time and In vitro dissolution studies. The formulation F8 prepared by using HPMC E50 as polymer and PEG-4000 as plasticizer shows the best result with minimum disintegration time of 45.78±0.521, % drug content of 99.03±0.276%, and 96.19±0.51% CDR within 10 minutes, with satisfactory physiological properties. The result of FT-IR showed that there is no incompatibility found between the drug and the excipients used in the formulations. This suggests that fast disintegrating mouth films of Betaxolol Hydrochloride could be potentially a useful formulation for the treatment of hypertension where quick onset of action is desired.
Suggested Citation
Dr. A. Geethalakshmi & Kunga Gyaltsen, 2018.
"Formulation and Comparative In-vitro Evaluation of Fast Disintegrating Mouth Films of Betaxolol Hydrochloride for Hypertension,"
International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 5(10), pages 34-39, October.
Handle:
RePEc:bjc:journl:v:05:y:2018:i:10:p:34-39
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjc:journl:v:05:y:2018:i:10:p:34-39. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrsi/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.